Stereotaxis Inc (STXS) Stock Price, Quote & News

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed t...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 314 678 6100

Website: www.stereotaxis.com

Address:

710 North Tucker Boulevard, Suite 110, Saint Louis, United States

DecoderRing Jun. 25 at 4:07 PM

$STXS Some days I feel like management is doing this on purpose. Suppose they have an offer at $3.50 or something (guessing) from $ABT and to avoid investor lawsuits, if they get the price down below $1 they will be able to say they were bought out at a respectable premium.

0 · Reply

S144 Jun. 25 at 5:36 AM

$STXS -29% YTD - quite bad .. @alexpitti : do you see a chance for at least some recovery later this year ?

1 · Reply

DecoderRing Jun. 25 at 1:34 AM

$STXS got the volume we were hoping for. Direction is the wrong way.

0 · Reply

Georges8792 Jun. 24 at 10:45 PM

$STXS waiting for a small recovery to sell my remaining shares. Best decision ever to get out of this crap

0 · Reply

Georges8792 Jun. 24 at 3:21 PM

$STXS Horrible

0 · Reply

brunoq14 Jun. 24 at 3:09 PM

$STXS End of quarter selling?

0 · Reply

alexpitti Jun. 23 at 5:53 PM

we getting smoked $STXS

1 · Reply

Waytobe360 Jun. 22 at 4:14 PM

$DFNS ugh. A lot of red flags, expect the need for exit liquidity soon. Looking at larger bets, $STXS $MU $TDG $PLTR

1 · Reply

no_ego Jun. 22 at 2:33 PM

$STXS pretty impressive move. Sales must be growing.

0 · Reply

Eddypgil Jun. 22 at 2:16 PM

$STXS volume much higher than normal

2 · Reply

Stereotaxis Slides: Investor presentation

2026-05-13T11:19:51.000Z - 6 weeks ago

Stereotaxis price target lowered to $3.50 from $4 at Piper Sandler

JNJ

May 12, 2026, 4:30 PM EDT - 6 weeks ago

Stereotaxis Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 6 weeks ago

Stereotaxis Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 6 weeks ago

Stereotaxis Quarterly report: Q1 2026

May 12, 2026, 4:06 PM EDT - 6 weeks ago

Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates

Apr 22, 2026, 7:58 AM EDT - 2 months ago

Stereotaxis Announces First MAGiC Procedures in the United States

Apr 21, 2026, 9:01 AM EDT - 2 months ago

Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026

Apr 15, 2026, 9:00 AM EDT - 2 months ago

Stereotaxis Transcript: M&A announcement

Apr 15, 2026, 9:00 AM EDT - 2 months ago

Stereotaxis Press release: M&A announcement

2026-04-15T11:12:19.000Z - 2 months ago

Stereotaxis to acquire Robocath, terms undisclosed

Apr 15, 2026, 7:00 AM EDT - 2 months ago

Stereotaxis Announces Definitive Agreement to Acquire Robocath

2026-04-06T12:40:34.000Z - 2 months ago

Stereotaxis receives FDA clearance for Synchrony system

Apr 6, 2026, 8:06 AM EDT - 2 months ago

Stereotaxis Announces FDA Clearance and Launch of Synchrony System

Apr 3, 2026, 8:00 AM EDT - 2 months ago

Stereotaxis Proxy statement: Proxy filing

Apr 3, 2026, 8:00 AM EDT - 2 months ago

Stereotaxis Proxy statement: Proxy filing

2026-03-13T20:30:19.000Z - 3 months ago

Stereotaxis files $100M mixed securities shelf

2026-03-13T19:35:41.000Z - 3 months ago

Stereotaxis management to meet virtually with BTIG

Mar 13, 2026, 8:00 AM EDT - 3 months ago

Stereotaxis Registration statement: Registration Filing

Mar 9, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 3 months ago

Stereotaxis Earnings release: Q4 2025

2026-03-09T20:05:19.000Z - 3 months ago

Stereotaxis reports Q4 EPS (6c), consensus (6c)

2026-03-09T20:05:10.000Z - 3 months ago

Stereotaxis sees FY26 revenue up double digits

Mar 9, 2026, 4:01 PM EDT - 3 months ago

Stereotaxis Reports 2025 Full Year Financial Results

Feb 12, 2026, 9:00 AM EST - 4 months ago

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

2026-02-09T13:37:08.000Z - 4 months ago

Stereotaxis announces launch of electrophysiology program at Klinikum Furth

Feb 9, 2026, 8:06 AM EST - 4 months ago

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

2026-01-06T13:39:16.000Z - 6 months ago

Stereotaxis reports FDA approval for MAGiC Ablation Catheter

Jan 6, 2026, 8:01 AM EST - 6 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

2025-12-16T09:40:34.000Z - 6 months ago

Stereotaxis initiated with an Outperform at Citizens

Nov 24, 2025, 8:58 AM EST - 7 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Earnings Call Transcript: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Quarterly report: Q3 2025

Nov 11, 2025, 4:30 PM EST - 8 months ago

Stereotaxis Earnings release: Q3 2025

2025-11-11T21:05:25.000Z - 8 months ago

Stereotaxis reports Q3 EPS (7c), consensus (6c)

Nov 11, 2025, 4:01 PM EST - 8 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

2025-11-10T22:01:01.000Z - 8 months ago

Stereotaxis announces FDA clearance for GenesisX

Nov 10, 2025, 4:05 PM EST - 8 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

2025-11-05T09:25:11.000Z - 8 months ago

Stereotaxis resumed with a Buy at Roth Capital

Oct 21, 2025, 9:00 AM EDT - 8 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

2025-10-15T11:35:16.000Z - 9 months ago

Stereotaxis announces EU launch, 510k submission for Synchrony system

Oct 15, 2025, 7:32 AM EDT - 9 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

2025-10-13T11:46:17.000Z - 9 months ago

Stereotaxis, CardioFocus collaborate to advance robotic PFA technology

Oct 13, 2025, 7:34 AM EDT - 9 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

2025-09-22T12:00:15.000Z - 9 months ago

Stereotaxis announces procedures using Genesis at Erasmus Medical Center

Sep 22, 2025, 7:56 AM EDT - 9 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

2025-09-02T12:40:31.000Z - 10 months ago

Stereotaxis announces completion of procedure using MAGiC Sweep

Sep 2, 2025, 8:08 AM EDT - 10 months ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 7:51 AM EDT - 10 months ago

Stereotaxis to Present at Upcoming Investor Conferences

Aug 28, 2025, 7:47 AM EDT - 10 months ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Stereotaxis Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Stereotaxis Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Stereotaxis Earnings release: Q2 2025

2025-08-07T20:21:40.000Z - 11 months ago

Stereotaxis reports Q2 EPS (5c), consensus (6c)

Aug 7, 2025, 4:01 PM EDT - 11 months ago

Stereotaxis Reports 2025 Second Quarter Financial Results

2025-07-28T11:55:43.000Z - 11 months ago

Stereotaxis receives FDA clearance for MAGiC Sweep catheter

Jul 28, 2025, 7:48 AM EDT - 11 months ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 23, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 17, 2025, 8:32 AM EDT - 1 year ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 1, 2025, 9:00 AM EDT - 1 year ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings Call Transcript: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Quarterly report: Q1 2025

May 12, 2025, 4:30 PM EDT - 1 year ago

Stereotaxis Earnings release: Q1 2025

May 12, 2025, 4:01 PM EDT - 1 year ago

Stereotaxis Reports 2025 First Quarter Financial Results

Apr 22, 2025, 7:00 AM EDT - 1 year ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing

Apr 4, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis Proxy statement: Proxy Filing

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 10, 2025, 8:02 AM EDT - 1 year ago

Stereotaxis to Present at 37th Annual Roth Conference

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Annual report: Q4 2024

Mar 3, 2025, 8:30 AM EST - 1 year ago

Stereotaxis Earnings release: Q4 2024

Mar 3, 2025, 7:32 AM EST - 1 year ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:31 AM EST - 1 year ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:30 AM EST - 1 year ago

Stereotaxis Reports 2024 Full Year Financial Results

Feb 25, 2025, 8:03 AM EST - 1 year ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 3, 2025, 4:05 PM EST - 1 year ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order

Jan 27, 2025, 8:00 AM EST - 1 year ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 14, 2025, 7:21 AM EST - 1 year ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Dec 9, 2024, 7:25 AM EST - 1 year ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 2, 2024, 8:45 AM EST - 1 year ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Nov 26, 2024, 8:28 AM EST - 1 year ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings Call Transcript: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Quarterly report: Q3 2024

Nov 11, 2024, 4:30 PM EST - 1 year ago

Stereotaxis Earnings release: Q3 2024

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Sep 6, 2024, 8:00 AM EDT - 1 year ago

Stereotaxis Registration statement: Registration Filing

Sep 3, 2024, 8:53 AM EDT - 1 year ago

Stereotaxis Robotic Technology to be Featured during Heart Rhythm Society's HRX Congress

Aug 23, 2024, 8:00 AM EDT - 1 year ago

Stereotaxis Registration statement: Registration Filing

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Earnings Call Transcript: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Quarterly report: Q2 2024

Aug 12, 2024, 4:30 PM EDT - 2 years ago

Stereotaxis Earnings release: Q2 2024

Aug 12, 2024, 4:05 PM EDT - 2 years ago

Stereotaxis Reports 2024 Second Quarter Financial Results

Aug 12, 2024, 4:03 PM EDT - 2 years ago

Stereotaxis Achieves CE Mark in Europe and Submits 510(k) in the US for Next Generation Robotic System GenesisX

Jul 22, 2024, 4:05 PM EDT - 2 years ago

Stereotaxis to Report Second Quarter 2024 Financial Results on August 12, 2024

Jul 18, 2024, 4:13 PM EDT - 2 years ago

Stereotaxis Strengthens Board of Directors with Appointment of Nachum Shamir

May 29, 2024, 8:25 AM EDT - 2 years ago

Penn Presbyterian Medical Center Becomes First Hospital in the Northeast to Adopt Advanced Robotic Technology for Heart Treatment

DecoderRing Jun. 25 at 4:07 PM

0 · Reply

S144 Jun. 25 at 5:36 AM

$STXS -29% YTD - quite bad .. @alexpitti : do you see a chance for at least some recovery later this year ?

1 · Reply

DecoderRing Jun. 25 at 1:34 AM

$STXS got the volume we were hoping for. Direction is the wrong way.

0 · Reply

Georges8792 Jun. 24 at 10:45 PM

$STXS waiting for a small recovery to sell my remaining shares. Best decision ever to get out of this crap

0 · Reply

Georges8792 Jun. 24 at 3:21 PM

$STXS Horrible

0 · Reply

brunoq14 Jun. 24 at 3:09 PM

$STXS End of quarter selling?

0 · Reply

alexpitti Jun. 23 at 5:53 PM

we getting smoked $STXS

1 · Reply

Waytobe360 Jun. 22 at 4:14 PM

$DFNS ugh. A lot of red flags, expect the need for exit liquidity soon. Looking at larger bets, $STXS $MU $TDG $PLTR

1 · Reply

no_ego Jun. 22 at 2:33 PM

$STXS pretty impressive move. Sales must be growing.

0 · Reply

Eddypgil Jun. 22 at 2:16 PM

$STXS volume much higher than normal

2 · Reply

Lordlittle Jun. 21 at 5:23 PM

$STXS looks like we will be getting diluted soon not good for us shareholders

1 · Reply

Ratman44 Jun. 19 at 3:37 PM

$STXS so this is a massive turning point. There are some really interesting dialogue in the linked in post comments. https://www.linkedin.com/posts/sabine-ernst-4418b115_epeeps-armabrep-3dmapping-ugcPost-7472584958319058944-Oc1H/?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAAAEPyhEB79dMOJESYKxHjUGqHBJaC0yodc0&utm_campaign=copy_link

3 · Reply

no_ego Jun. 18 at 5:27 PM

$STXS one report of MAGIC malfunctioning and stock price hits $1.

2 · Reply

alexpitti Jun. 17 at 7:52 PM

the fed ruined our winning day. wow $MIST $STXS $DCTH $ABEO

2 · Reply

Daquanladariusblackman3 Jun. 17 at 5:20 PM

$STXS almost nonexistent volume here. Interest in this product and company is just not there. Declining revenue even with years to attract interest is the problem, nobody has a use for the thing.

1 · Reply

no_ego Jun. 17 at 2:54 PM

$STXS apparently the catheter in the Magic is problematic

0 · Reply

Boomer52 Jun. 17 at 12:04 PM

$STXS What are the Chances Hospitals Will Buy the MAGiC Device? For hospitals that already own a Stereotaxis Genesis system, the adoption rate for the MAGiC catheter is expected to be incredibly high. These hospitals have already made the multi-million dollar capital investment and have been eagerly awaiting a proprietary, FDA-approved magnetic catheter to fully maximize the value of their robotic labs. For hospitals without the existing robotic infrastructure, the purchase likelihood is a steady, specialized climb: High Probability in Tier-1 Academic Centers. Lower Probability in Community/Regional Hospitals. The ball now is entirely in Stereotaxis' commercial court to prove to hospital CFOs that the clinical benefits justify the investment. They have their work cut out. Look at their website dedicated to convincing hospitals they need and can’t afford NOT to invest in their equipment. https://www.roboticep.com/hospitals/

1 · Reply

Daquanladariusblackman3 Jun. 16 at 2:32 PM

$STXS heading to the 52 week low

0 · Reply

Daquanladariusblackman3 Jun. 16 at 1:39 PM

$STXS it’ll be a long time before this penny stock goes back over $2

0 · Reply

DecoderRing Jun. 16 at 1:13 PM

$STXS Wonder if any hospital questions their ability to stay in business? Its a decent investment, but without a strategic partner backstopping the vision, questions and uncertainty prevail.

1 · Reply

no_ego Jun. 15 at 4:52 PM

$STXS may be a long time before this penny stock sees 2

0 · Reply

no_ego Jun. 15 at 12:39 PM

$STXS troubling sales results

0 · Reply

Market Cap	171.04M
Revenue (ttm)	32.38M
Net Income (ttm)	-21.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.83%
Debt to Equity Ratio	0.00

Volume	293,914
Avg Vol	395,350
Day's Range	N/A - N/A
Shares Out	97.74M
Stochastic %K	0%
Beta	1.35
Analysts	Strong Sell
Price Target	$4.12